IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.
- DOI
- 10.1038/s41467-025-58868-2
- Published
- 2025 Apr 23
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-025-58868-2,
title = {IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.},
author = {Domizi P and Sarno J and Jager A and Merchant M and Pacheco KZB and Yamada-Hunter SA and Rotiroti MC and Liu Y and Baskar R and Reynolds WD and Sworder BJ and Sahaf B and Bendall SC and Mullighan CG and Alizadeh AA and Leahy AB and Myers RM and Yates B and Wang HW and Shah NN and Majzner RG and Mackall CL and Grupp SA and Barrett DM and Sotillo E and Davis KL},
year = {2025},
journal = {Nature communications},
doi = {10.1038/s41467-025-58868-2},
url = {https://doi.org/10.1038/s41467-025-58868-2}
}RIS
TY - JOUR TI - IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies. AU - Domizi P AU - Sarno J AU - Jager A AU - Merchant M AU - Pacheco KZB AU - Yamada-Hunter SA AU - Rotiroti MC AU - Liu Y AU - Baskar R AU - Reynolds WD AU - Sworder BJ AU - Sahaf B AU - Bendall SC AU - Mullighan CG AU - Alizadeh AA AU - Leahy AB AU - Myers RM AU - Yates B AU - Wang HW AU - Shah NN AU - Majzner RG AU - Mackall CL AU - Grupp SA AU - Barrett DM AU - Sotillo E AU - Davis KL PY - 2025 JO - Nature communications DO - 10.1038/s41467-025-58868-2 UR - https://doi.org/10.1038/s41467-025-58868-2 ER -
APA
P, D., J, S., A, J., M, M., KZB, P., SA, Y., MC, R., Y, L., R, B., WD, R., BJ, S., B, S., SC, B., CG, M., AA, A., AB, L., RM, M., B, Y., HW, W., NN, S., RG, M., CL, M., SA, G., DM, B., E, S., & KL, D. (2025). IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.. Nature communications. https://doi.org/10.1038/s41467-025-58868-2
Source records
- pubmed · retrieved 2026-09-25T23:51:33.004Z